| Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma TF Cloughesy, AY Mochizuki, JR Orpilla, W Hugo, AH Lee, TB Davidson, ... Nature medicine 25 (3), 477-486, 2019 | 1086 | 2019 |
| Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration JS Yu, CJ Wheeler, PM Zeltzer, H Ying, DN Finger, PK Lee, WH Yong, ... Cancer research 61 (3), 842-847, 2001 | 694 | 2001 |
| Hospitalization rates and characteristics of children aged 18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1–July 25, 2020 L Kim MMWR. Morbidity and mortality weekly report 69, 2020 | 633 | 2020 |
| Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ... Acta neuropathologica 121, 381-396, 2011 | 632 | 2011 |
| Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma JS Yu, G Liu, H Ying, WH Yong, KL Black, CJ Wheeler Cancer research 64 (14), 4973-4979, 2004 | 625 | 2004 |
| Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme A Lai, A Tran, PL Nghiemphu, WB Pope, OE Solis, M Selch, E Filka, ... Journal of clinical oncology 29 (2), 142, 2011 | 562 | 2011 |
| CT and MRI early vessel signs reflect clot composition in acute stroke DS Liebeskind, N Sanossian, WH Yong, S Starkman, MP Tsang, AL Moya, ... Stroke 42 (5), 1237-1243, 2011 | 546 | 2011 |
| Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ... Journal of clinical oncology 29 (34), 4482, 2011 | 524 | 2011 |
| Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy RM Prins, H Soto, V Konkankit, SK Odesa, A Eskin, WH Yong, SF Nelson, ... Clinical cancer research 17 (6), 1603-1615, 2011 | 513 | 2011 |
| Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience JT Lerner, N Salamon, JS Hauptman, TR Velasco, M Hemb, JY Wu, ... Epilepsia 50 (6), 1310-1335, 2009 | 491 | 2009 |
| An introduction to performing immunofluorescence staining K Im, S Mareninov, MFP Diaz, WH Yong Biobanking: methods and protocols, 299-311, 2019 | 407 | 2019 |
| mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc K Masui, K Tanaka, D Akhavan, I Babic, B Gini, T Matsutani, A Iwanami, ... Cell metabolism 18 (5), 726-739, 2013 | 404 | 2013 |
| Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy WB Pope, RM Prins, M Albert Thomas, R Nagarajan, KE Yen, MA Bittinger, ... Journal of neuro-oncology 107, 197-205, 2012 | 372 | 2012 |
| Differential sensitivity of glioma-versus lung cancer–specific EGFR mutations to EGFR kinase inhibitors I Vivanco, HI Robins, D Rohle, C Campos, C Grommes, PL Nghiemphu, ... Cancer discovery 2 (5), 458-471, 2012 | 365 | 2012 |
| FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy N Salamon, J Kung, SJ Shaw, J Koo, S Koh, JY Wu, JT Lerner, R Sankar, ... Neurology 71 (20), 1594-1601, 2008 | 360 | 2008 |
| EGFR signaling through an Akt-SREBP-1–dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy D Guo, RM Prins, J Dang, D Kuga, A Iwanami, H Soto, KY Lin, TT Huang, ... Science signaling 2 (101), ra82-ra82, 2009 | 359 | 2009 |
| Oncogenic EGFR signaling activates an mTORC2–NF-κB pathway that promotes chemotherapy resistance K Tanaka, I Babic, D Nathanson, D Akhavan, D Guo, B Gini, J Dang, ... Cancer discovery 1 (6), 524-538, 2011 | 332 | 2011 |
| Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177 PD Brown, S Krishnan, JN Sarkaria, W Wu, KA Jaeckle, JH Uhm, ... Journal of Clinical Oncology 26 (34), 5603, 2008 | 318 | 2008 |
| Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma JA Carrillo, A Lai, PL Nghiemphu, HJ Kim, HS Phillips, S Kharbanda, ... American Journal of Neuroradiology 33 (7), 1349-1355, 2012 | 308 | 2012 |
| Neuropathology E-book: a reference text of CNS pathology D Ellison, S Love, LMC Chimelli, B Harding, JS Lowe, HV Vinters, ... Elsevier Health Sciences, 2012 | 293 | 2012 |
Timothy CloughesyUCLAVerified email at mednet.ucla.edu
